1. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
- Author
-
Black LV, Saunderson SC, Coutinho FP, Muhsin-Sharafaldine MR, Damani TT, Dunn AC, and McLellan AD
- Subjects
- Animals, Biotinylation, Cell Line, Tumor, Doxorubicin pharmacology, Extracellular Vesicles drug effects, Extracellular Vesicles ultrastructure, Mice, Inbred C57BL, Staurosporine pharmacology, Apoptosis drug effects, Cytotoxicity, Immunologic drug effects, Extracellular Vesicles metabolism, Lymphoma immunology, Lymphoma pathology, Sialic Acid Binding Ig-like Lectin 1 metabolism, T-Lymphocytes, Cytotoxic drug effects
- Abstract
Apoptosis leads to the fragmentation and packaging of cellular contents into discrete vesicles, a process known as 'blebbing'. Extracellular vesicles express membrane-bound sialic acids, which enable their capture by CD169 (sialoadhesin; Siglec-1) expressing macrophages in the lymph node and spleen. Furthermore, CD169 mediates vesicle trafficking and suppresses the immune response to exosomes-a type of extracellular vesicle released from living cells. In this study, we found that CD169(+) macrophages were the predominant splenic macrophage subset responsible for the capture of EL4 lymphoma-derived apoptotic vesicles (ApoVs) from circulation. CD169(-/-) mice had significantly enhanced in vivo cytotoxic T lymphocyte responses to antigen-pulsed ApoVs, indicating a suppressive role for CD169(+) macrophages to ApoV-associated antigen. In contrast to the observed immunogenic role of ApoVs, the co-administration of unpulsed ApoVs with antigen-pulsed dendritic cells (DCs) significantly suppressed DC-mediated cytotoxic response in vivo; however, this occurred independent of CD169 expression. Overall, our results confirm that apoptosis contributes to both tolerance and immunity, as well as establishing CD169 as a critical mediator of the immune response to extracellular vesicles.
- Published
- 2016
- Full Text
- View/download PDF